Lobbying client

POLARITYTE, INC.

Regenerative human tissue products

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
14
Filed by
2
Reported in-house
—
Reported by firms
$320,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2018 to 2020

Filings

14 filings, newest first.
Filing Filed by Amount
2nd Quarter - Termination
2nd Quarter 2020
JEFFREY J. KIMBELL & ASSOCIATES, INC. $30,000 reported
2nd Quarter - Termination
2nd Quarter 2020
C2 STRATEGIES $10,000 reported
1st Quarter - Report
1st Quarter 2020
JEFFREY J. KIMBELL & ASSOCIATES, INC. $30,000 reported
1st Quarter - Report
1st Quarter 2020
C2 STRATEGIES $30,000 reported
4th Quarter - Report
4th Quarter 2019
JEFFREY J. KIMBELL & ASSOCIATES, INC. $30,000 reported
4th Quarter - Report
4th Quarter 2019
C2 STRATEGIES $30,000 reported
3rd Quarter - Report
3rd Quarter 2019
C2 STRATEGIES $30,000 reported
3rd Quarter - Report
3rd Quarter 2019
JEFFREY J. KIMBELL & ASSOCIATES, INC. $30,000 reported
2nd Quarter - Report
2nd Quarter 2019
C2 STRATEGIES $30,000 reported
2nd Quarter - Report
2nd Quarter 2019
JEFFREY J. KIMBELL & ASSOCIATES, INC. $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
JEFFREY J. KIMBELL & ASSOCIATES, INC. 7 $190,000
C2 STRATEGIES 5 $130,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 8
Defense DEF 6

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.